Temodal is indicated for the treatment of patients with glioblastoma multiforme or anaplastic astrocytoma who have relapsed or progressed after standard therapy. In addition, Temodal is indicated as a first-line therapeutic agent in the treatment of patients with advanced metastatic malignant melanoma.
Active ingredient: temozolamide
Prescription medicine
Дозировка | 5 Mg, 20 Mg, 100 Mg, 250 Mg |
---|